Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.23.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Operating activities          
Net loss $ (96,753) $ (207,427) $ (184,033) $ (429,389)  
Adjustments to reconcile net loss to net cash used in operations          
Amortization of debt discount     5,670 9,098  
Accreted interest on note receivable     (3,308)  
Net loss from equity method investment     46,030  
Unrealized (gain) loss on available - for - sale securities     (6,644) 231,183  
Decrease (Increase) in          
Accounts receivable – related party     45,000 (22,500)  
Interest receivable     (7,690)  
Increase in          
Accounts payable and accrued expenses     87,096 115,561  
Accounts payable and accrued expenses - related party     60,000  
Accumulated losses on unconsolidated investees in excess of investment     1,226  
Net cash used in operating activities     (52,911) 211  
Net decrease in cash and cash equivalents     (52,911) 211  
Cash and cash equivalents - beginning of period     235,311 227,558 $ 227,558
Cash and cash equivalents - end of period $ 182,400 $ 227,769 182,400 227,769 $ 235,311
Supplemental disclosure of cash flow information          
Cash paid for interest      
Cash paid for income tax      
Supplemental disclosure of non-cash investing and financing activities          
Investment at fair value received from issuance of note receivable